As it is widely recognized, India has been making strides in various industries such as science, technology, space, and automobiles. However, there is a critical and pressing need to prioritize and invest in research and development, as well as innovation programs, in India.
In particular, the field of drug discovery and generic pharmaceuticals in India requires attention. It’s worth noting that there are over 450 pharmaceutical companies worldwide, with the United States accounting for 40%, China for 30%, and India for only 5-6%, as per a published article. This indicates that we are currently falling behind in terms of research and innovation in this area. Despite the presence of strong research institutions like CSIR, IITs, and others, India has not yet been able to launch its own indigenous drugs. However, there is a positive development as the country is getting closer to discovering new NCEs (new chemical entities). In the past, some Indian companies have successfully developed NCEs, but the challenge lies in launching these drugs as only a few studies have progressed to phase III or beyond.
Following the discussion on the need for increased focus on drug discovery and innovation in India, Allmpus Laboratory Pvt. Ltd. has decided to launch a drug discovery program in the country. As a result, Allmpus will be starting its first CDD (new drug discovery and development) lab within the next 2-3 months. As a research and development (R&D) company, Allmpus is committed to investing in and prioritizing discovery and research programs in India.
About Allmpus
Based out of Mumbai, Allmpus Laboratories Private Limited is a research-based pharmaceutical company that offers flexible solutions to customers through science and innovation. It is the leading manufacturer and supplier of impurity standards as per Pharmacopeia for API-related compounds, process impurities, and metabolites that are acceptable to all regulatory agencies & also used for ANDA filing, DMF filing, and genotoxic studies.
With its dynamic approach and strategies, Allmpus has made its own place in the market due to its extensive product catalogs, high quality, on-time delivery, technical support, and the best price in the market.
The Dynamic CEO
Dr. Atish Rodge (Ph.D.) Dr. Atish started the company in 2013 with the vision of a growing pharmaceutical company in India and the world, innovation through research& and a flexible solution for the pharma business.
He started a business as a manufacturer of pharmaceutical standards and supplied them to all MNCs in India as well as around the world. Along with Allmpus, only 1-2 companies are in the same business, and the company has invented some unique products and pharmaceutical standards that are not available anywhere, which makes Allmpus distinctive from the rest in the market and is the leading research strength of the company.
“My own interest was to start a drug discovery program for the country of India, and hopefully, in 2023–24, we are going to begin our innovation in drug discovery on cancer and inflammation. My dream is to launch our own drug from the company Allmpus, I am ready to go for discovery, and we are planning to set up the best R&D program for our nation, India“, says Dr. Atish.
Drug Discovery and NDDD-Allmpus
Allmpus is starting its discovery program by focusing research on natural products, as India has very good background and lecture support for Ayurveda, as well as good climate support for many medicinally important species.
To get the success in the above research, Allmpus tries to collaborate with Indian research institutions and private research companies and also takes expert opinion from Indian scientists, consultants, and researchers.
Allmpus tries to involve academics, college institutions, and PhD fellows as part of the discovery program. Along with natural products, Allmpus starts library synthesis of NCE based on computational studies and screens against different therapeutic areas or targets using in vitro or modern techniques like HTS.
Dr. Atish strongly believes his team as well as his country doing well in upcoming years in discovery program and it will be launched or announced first Indian drug.
Unique Products and Services Offered
Allmpus is the fastest growing pharma company, with a total of 20,000 employees and a 6,000-square-foot R&D center.The best strategy for the company is to focus on the unique product range and development of unique pharmaceutical intermediates, which have a high price but low volume.
The company focuses on the quality, delivery time, and price of the products and believes in long-term association and work with clients. It considers clients’ timelines and budgets very important, while drug discovery is the main strategy of Allmpus in the upcoming year.
The Luminous Future of Allmpus
On asking the founder of the laboratories what their future plans are, he asserts, “We are currently working on the formulations for some new drugs and recipes that we are about to release in the next 2-3 months within the last quarter of 2022. Furthermore, we also have plans to start off another 7,000-square-foot research unit in the next 6 to 7 months“.
The growth of Allmpus reflects the upcoming success of India’s pharmaceutical industries. The residing opportunities to grow, uplink, and expand are plenty and are waiting to be heeded. Undoubtedly, with the amazing leadership of Dr. Atish, Allmpus has become the most distinctive leader in the booming pharmaceutical valley of India.
